Combined Cytokine Blocking Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft Versus Host Disease (SR-GvHD)

Background Despite improved advances in graft-vs-host disease (GvHD) prophylaxis regimens and post-allogeneic hematopoietic cell transplant (HCT) supportive care, clinically significant acute GvHD still develops in approximately 30-50% of HCT recipients (Lazaryan A et al. BMT 2016) and often results...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.4944-4944
Hauptverfasser:	Pourhassan, Hoda, Nguyen, Tina, Yang, Dongyun, Othman, Tamer, Koller, Paul B., Blackmon, Amanda, Agrawal, Vaibhav, Ball, Brian J., Amanam, Idoroenyi, Arslan, Shukaib, Otoukesh, Salman, Sandhu, Karamjeet S., Aldoss, Ibrahim, Ali, Haris, Salhotra, Amandeep, Aribi, Ahmed, Artz, Andrew, Becker, Pamela S., Pullarkat, Vinod, Stewart, Forest Marc, Smith, Eileen Patricia, Stein, Anthony, Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Al Malki, Monzr M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!